ArticleFrontiers in medicine2020

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies.

Luca Petricca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.